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MODULATION OF  HUMAN LYMPHOCYTE FUNCTION 
BY C3a AND C3a(70-77)* 
BY D. G. PAYAN, D. E. TRENTHAM, AND E. J. GOETZL 
From the Howard Hughes Medical Institute LaboratoTy at Harvard Medical School, the Department of 
Medicine, Harvard Medical School, and the Division of Rheumatology and Immunology of the Brigham and 
Women's Hospital, Boston, Massachusetts 02115 
The possibility that the third component of complement, C3, might regulate 
immune responses and other specific activities of lymphocytes was suggested initially 
by the effects on lymphocyte function of complement depletion in vivo (1) and the 
introduction of C3 in vitro (2-5). C3 and partially purified C3a, the fragment of C3 
that exhibits anaphylatoxin activity (6), inhibit the transformation of rat and human 
lymphocytes incubated with mitogenic lectins in serum-free medium, as assessed by 
suppression of the increased lymphocyte uptake of [~H]thymidine (5, 7). Analyses of 
the cellular specificity of partially purified C3a have indicated that the proliferative 
responses of rat B lymphocytes are more susceptible to inhibition than those of T 
lymphocytes (7). Both purified human C3a and the synthetic octapeptide C3a(70- 
77), which retains the activities of an anaphylatoxin (6, 8), now are shown to interact 
directly with human lymphocytes, as evidenced both by selective inhibition of the T 
lymphocyte migration and lymphokine generation elicited by diverse stimuli and by 
the reduced lymphokine-generating activity of lymphocytes exposed to solid-phase 
C3a(70-77). 
Materials and Methods 
Medium 199, Hanks' balanced salt solution, Eagle's minimal essential medium, aMASH II 
cell harvester (M. A. Bioproducts, Walkersville, MD), activated CH-Sepharose 4B, Sephadex 
G-10, 25, 75, and 100, SP-Sephadex, QAE-Sephadex, macromolecular dextran (Macrodex), 
and Ficoll-Hypaque (Pharmaeia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N J), 4- 
(2-hydroxyethyl)-1-piperazine-ethanesulfonie acid (Hepes), penicillin G, streptomycin (Gibco 
Laboratories, Grand Island Biological Co., Grand Island, NY), five times recrystallized oval- 
bumin, concanavalin A (Con A) 1 (Miles Laboratories, Inc., Elkhart, IN), phytohemagglutinin- 
M (PHA) (Difeo Laboratories, Inc., Detroit, MI), streptokinase-streptodornase (SK-SD) (Led- 
erie Laboratories Inc., Pearl River, NY), a-thioglycerol (Sigma Chemical Co., St. Louis, MO), 
Drummond glass capillary tubes (Bolab, Inc., Derry, NH), murine monoclonal ntibodies to 
human leukocyte surface antigens (Ortho Diagnostics, Inc., Westwood, MA) (9), MacKaness- 
type plastic chambers (Adaps, Inc., Dedham, MA), [nH]thymidine (New England Nuclear, 
Boston, MA), 3-/~m pore and 8-/zm pore membrane filters (Sartorius Filters, Hayward, CA), 8- 
/~m channel filters (Nuclepore Corp., Pleasanton, CA), and chemotactic chambers with a 0.2- 
ml blind-end stimulus compartment (Neuroprobe, Inc., Bethesda, MD) were obtained from the 
* Supported inpart by grants AM-21490 and AM-20850 from the National Institutes ofHealth, and 
from the Massachusetts chapter of the American Red Cross. 
1 Abbreviations u ed in this paper: Con A, concanavalin A; HBSS-OA, Hanks' balanced salt solution 
containing 0.2 g ovalbumin/100 ml; LIF, leukocyte inhibitory factor; PHA, phytohemagglutinin; PMN, 
polymorphonuclear ukocytes; SK-SD, streptokinase-streptodornase. 
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specified suppliers. 
Chemotactic fragments of the fifth component of human complement (C5fr) were purified 
from zymosan=activated human serum as described (10). C3a was generated by incubating 
fresh human serum with 10 mg/ml of zymosan in the presence of 1 M e-amino-caproic a id 
and purified by sequential filtration on Sephadex G-100 in 0.1 M ammonium formate (pH 
5.0), ion-exchange chromatography on SP-Sephadex and QAE-Sephadex, and gel filtration on 
Sephadex G-75 in 0.05 M ammonium formate (pH 5.0) (11). The C3a was quantified by a 
standard protein assay (Bio-Rad Laboratories, Richmond, CA), its capacity to contract 
segments of guinea pig ileum, and reactivity with monospecific anti-human C3 in a standard 
immunodiffusion assay (6, 11). The octapeptide Ala-Ser-His-Leu-Gly-Leu-Ala-Arg, C3a(70- 
77), was prepared by standard solid-phase synthesis techniques and purified by filtration on 
Sephadex G-25 in 0.01 M acetic acid and counter-current distribution (12). C3a(70-77) was 
coupled by the terminal amino-group to CH-Sepharose 4B by reacting 1 g of activated CH- 
Sepharose 4B with 10 gmoles of C3a(70-77) in 5 ml of 0.5 M NaCI-0.1 M NaHCO3 (pH 7.4) 
for 1 h at room temperature under a N2 atmosphere. The product was washed twice with 200 
ml each of 1 M NaC1-0.1 M sodium acetate (pH 4.0), 1 M NaC1-0.1 M Tris-HC1 (pH 8.0), and 
distilled water and stored in 0.01 M acetic acid at 4°C under N2 for up to 1 wk. Amino acid 
analyses of portions of the gel that had been hydrolyzed for 8 h at 160°C in propionic acid:HC1 
(1 : 1 ; vol/vol) indicated a coupling of 2.6-2.8 gmoles of C3a(70-77) per ml of CH-Sepharose 4B 
(range, n = 3). CH-Sepharose to which had been coupled the same quantity of glycine served 
as the adsorbent in control columns. 
Isolation of Human Leukocytes. Leukocytes from normal donors were obtained and processed 
under sterile conditions for the production and quantification of leukocyte inhibitory factor 
(LIF) activity in the glass capillary tube assay and the assessment of lymphocyte proliferation. 
After dextran sedimentation f the erythrocytes in heparinized blood, the mixed leukocytes in 
the plasma were sedimented by centrifugation, washed, and resuspended in medium 199 
containing 25 mM Hepes (pH 7.4), penicillin (100 U/ml), and streptomycin (100 /xg/ml) 
(M199-HPS) (13). 10-ml portions of 2 × 106 leukocytes/ml were layered on 10-ml Ficoll- 
Hypaque cushions (sp gr, 1.076) and centrifuged at 500 g for 35 min at room temperature (13). 
The mononuclear leukocytes at the buffer-gradient interface were harvested and washed twice 
in M199-HPS. The polymorphonuclear leukocytes (PMN) in the pellet were resuspended in 1 
ml of AB-positive human serum that was diluted to 10 ml with distilled water at room 
temperature to lyse contaminating erythroeytes. After 20 s, 40 ml of M199-HPS was added, 
and the PMN were recovered by centrifugation and washed twice with M 199-HPS. The purity 
of the preparations was >95% for the PMN and >93% for the mononuclear leukocytes. 
PMN and T lymphocytes for studies of leukocyte migration in the modified Boyden chamber 
assay were isolated from citrate-anticoagulated v nous blood of normal subjects, as described 
(10, 14). The mixed leukocytes were incubated in 0.84 g/100 ml NH4C1 with 0.01 M NaHCO3 
(pH 7.2) for 2 min at room temperature to lyse contaminating erythroeytes, washed, resuspended 
in Hanks' solution containing 0.2 g ovalbumin/100 ml (HBSS-OA) and centrifuged on cushions 
of Ficoll-Hypaque to yield PMN of>95% purity and mononuclear leukocytes (15). The PMN 
were washed and resuspended in HBSS-OA. 5-ml portions of the suspension of 4 × l07 
mononuclear leukocytes/ml in Eagle's medium with 0.2 g ovalbumin/100 ml were each applied 
to a column of 10 ml of Sephadex G-10 on 5 ml of nylon wool that was equilibrated and 
developed with 45 ml of the same medium. The leukocytes in the effluent were 92-96% T 
lymphocytes (range, n = 6), as assessed by quantifying the rosetting of sheep erythrocytes 
without and with surface C3b or C3d and by analyzing the surface immunoglobulins (14). For 
the preparation ofT lymphocytes for LIF studies, mononuelear leukocytes from Ficoll-Hypaque 
cushions were incubated with neuraminidase-treated fr sh sheep erythrocytes to achieve roset- 
ring. The T lymphocytes were recovered from Ficoll-Hypaque cushions after lysis of the 
erythrocytes by hypotonic exposure, as described (16); the purity of the T lymphocytes always 
exceeded 95%. 
Purification and Quantification fLIF. Replicate 2-ml suspensions of 6-8 × 106 mononuclear 
leukocytes or purified T lymphoeytes per ml in M199-HPS containing 10% (vol/vol) AB- 
positive serum were cultured without or with 10/xg/ml of Con A, PHA, or SK-SD for 24 h at 
37°C in a humidified atmosphere of 5% CO2:95% air. Unless otherwise indicated, C3a or 
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C3a(70-77) was added to cultures at the same time as the mitogen or antigen stimulus. The 
same concentration of stimulus was added to control cultures at 24 h, immediately before 
centrifugation of all of the cultures at 1,050 g for 10 rain at room temperature to obtain 
leukocyte-free supernatants. 
Sterile suspensions of PMN were washed and resuspended in 6 volumes of M199-HPS 
containing 15% (vol/vol) AB-positive human serum. 20-#1 sterile glass capillary tubes were 
filled with the PMN suspension, centrifuged, cut at the level of the PMN pellet, and placed in 
duplicate on glass cover slips in MacKaness-type plastic chambers that were filled with LIF- 
containing or control supernatant and incubated for 8 h at 37°C (13, 17). The area of migration 
of PMN from each capillary tube was quantified by projection microscopy and planimetry, as 
described (13), and the LIF activity in stimulated'supernatants was calculated by the formula: 
mean percent inhibition of migration = 1 - ([mean area of migration from four capillaries in 
supernate of stimulated cultures]/[mean rea of migration from four capillaries in supernate of 
control cultures]) × 100. 
PMN chemotaxis was assessed in modified Boyden chambers with C5fr as the stimulus, and 
the responses were quantified by microscopic counting of the PMN in fixed and stained filters, 
as described (10, 17). Chemotactic responses were expressed as mean net PMN per high-power 
field after subtraction of the mean value for filters of chambers lacking C5fr. To measure the 
activity of LIF, PMN were incubated for 10 min at 37°C with 1A0 dilutions ofsupernatant from 
stimulated and control cultures before adding the leukocytes to the chemotactic chambers. 
Mean percent inhibition of migration in duplicate chambers was calculated as for the capillary 
tube method. The mean percent inhibition of migration by supernatants with C3a or C3a(70- 
77) was corrected for the level of inhibition observed when the same concentration of peptide 
alone was added to the assay, which never exceeded 20% in the capillary tube method or 5% in 
the chemotactic method. 
Assessment of Lymphocyte Proliferation. 2 × 105 mononuelear leukocytes in 0.2 ml of M199- 
HPS containing 15% (vol/vol) AB-positive serum were added to each well of microtiter plates 
without or with 10 #g/ml of Con A, PHA, or SK-SD and incubated at 37°C in 5% CO2:95% 
air. C3a or C3a(70-77) was introduced into some suspensions at the same time as the stimulus 
or buffer. After 3 d for the mitogen-stimulated cultures and 5 d for the SK-SD-stimulated 
cultures, 1/zCi of [aH]thymidine was added to each well. After an additional 16 h at 37°C, the 
uptake of [aH]thymidine was analyzed by aspirating the contents of each well with a Mash II 
harvester that collected and washed the leukocytes on glass fiber filters, as described (18). The 
radioactivity in each filter was quantified, and the results for quadruplicate chambers were 
expressed as mean cpm + SEM. The percentage inhibition of lymphocyte uptake of 
[aH]thymidine by C3a or C3a(70-77) was calculated from the ratio of the net uptake of 
radioactivity of stimulated lymphocytes in the presence of peptide to that in the absence of 
peptide (5). 
Measurement of T Lymphocyte Migration. T lymphocyte migration was quantified in modified 
Boyden chambers. The upper compartment ofeach chamber, containing 0.5 ml of a suspension 
of 5-6 × 10 s T lymphocytes in HBSS-OA, was separated from the lower compartment 
containing 0.2 ml of HBSS-OA by a layer consisting of an 8-/~m pore Nuclepore filter over an 
8-/zm pore Sartorius filter (14). C3a or C3a(70-77) without or with Con A or a-thioglycerol was 
added at equal concentrations to both compartments, and the chambers were incubated for 4 
h at 37°C in 5% CO2:95% air. The T lymphoeytes that migrated in the front at 60-80 #m from 
the cell source were enumerated in 10 high power fields in filters from duplicate chambers. The 
migration of T lymphocytes in the presence of C3a or C3a(70-77) is expressed as a percent of 
that in buffer or a stimulus alone. The levels of significance of the differences in all assays were 
analyzed by the standard Student's t test. 
Resul ts  
Inhibition of the Generation of LIF Activity by C3a and C3a(70-77). Incubation of 
normal human mixed mononuclear leukocytes with the mitogens PHA and Con A or 
the antigen SK-SD for 24 h at 370C resulted in the generation of  substantial levels of  
LIF activity, as assessed by the capacity of the culture supernatants to inhibit the 
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migration of human PMN from glass capillary tubes (Figs. 1-3). The introduction of 
C3a or C3a(70-77) into the mononuclear leukocyte cultures along with the mitogen 
or antigen at the onset of incubation resulted in a peptide concentration-dependent 
inhibition of the generation of LIF activity, irrespective of the stimulus. The extent of 
suppression of the generation of LIF activity was significant at concentrations of
C3a(70-77) of 10 -7 M or greater for each of the stimuli and exceeded 75% suppression 
at 10 -6 M C3a(70-77) (Figs. 1-3). The concentration of C3a(70-77) required to 
achieve 50% inhibition of LIF generation (ICso) was ~ 10 -s M for Con A and PHA 
and 10 -7 M for SK-SD. The suppression by C3a of the generation of LIF activity by 
mononuclear leukocytes exhibited a similar peptide concentration-suppression rela- 
tionship as that observed with C3a(70-77) for the mitogen stimuli (Figs. 1 and 2), as 
assessed by the examination of ICs0 values. The potency of C3a was more than 
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FIG. 1. Effect of C3a and C3a(70-77) on the generation of LIF activity by human peripheral 
blood mononuclear leukocytes stimulated with PHA. LIF was quantified by the inhibition of human 
PMN migration from glass capillary tubes. Each bar and error bracket represents he mean + SEM 
for the group of data points. Each P value indicates the level of significance of the difference between 
the samples with PHA and C3a or C3a(70-77) and those with PHA alone. 
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FIc. 2. Effect of C3a and C3a(70-77) on the generation of LIF activity by human peripheral 
blood mononuclear leukocytes timulated with Con A. LIF was quantified by the inhibition of 
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human PMN migration from glass capillary tubes. Each bar and error bracket represents he mean 
+ SEM for the group of data points. Each P value indicates the level of significance of the difference 
between the samples with SK-SD and C3a or C3a(70-77) and those with SK-SD alone. 
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10-fold higher than that of C3a(70-77) with respect to the suppression of L IF  
generation evoked by the antigen SK-SD (Fig. 3). Quanti f icat ion of L IF  activity by 
the inhibit ion of chemotaxis of PMN to C5fr in a Boyden chamber  assay corroborated 
the results of the capi l lary tube assay for LIF,  despite the greater inhibitory activity 
of L IF  in the former assay (Fig. 4). The ICs0 for the suppression of L IF  generation was 
~10 -s M C3a(70-77) with Con A as the stimulus and was 10 -7 M C3a(70-77) with 
SK-SD, which were identical to the respective values obtained with the capi l lary tube 
assay. 
When C3a(70-77) was added to the cultures either I h before or after PHA or Con 
A, the extent of suppression of the generation of L IF  activity elicited by either mitogen 
was not significantly different from the results in the standard experimental  protocol, 
where the mitogen and C3a(70-77) were added together at the beginning of  the 24-h 
incubation interval. That  the suppressive ffect of C3a and C3a(70-77) was attr ib- 
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utable to inhibition of the generation or release of LIF, rather than interference with 
the expression of LIF activity, was demonstrated by two separate approaches. First, 
the addition of 10 -9 M to 10 -8 M C3a(70-77) or of 10 -8 M to 10 -8 M C3a to LIF- 
containing supernatants after removal of the mononuclear leukocytes did not diminish 
the LIF activity detected in either the capillary tube or Boyden chamber assay. 
Second, the amount of LIF recovered by gel filtration from supernatants of cultures 
stimulated by mitogen without or with C3a(70-77) was directly proportional to the 
quantity found by assays of the unpurified supernatants before the resolution of LIF 
from C3a(70-77). Two sets of duplicate supernatants were prepared from 2 × 108 
mononuclear leukocytes in 60 ml of M199-HPS containing 10% AB-positive serum 
and 10 gg/ml of PHA, one set of which contained 10 -6 M C3a(70-77). The 
supernatants were lyophilized, redissolved in 3 ml of distilled water, dialyzed against 
distilled water for 24 h at 4°C, and filtered on a column of Sephadex G-100 that was 
equilibrated and developed with M199-HPS as described (17). The portions of the 
effluent that contained LIF activity were pooled and concentrated by pressure 
filtration (Amicon, Inc., Bedford, MA) to 3 ml. The LIF activity detected by the 
capillary tube method was 43 + 3% (mean -+_ SEM) for the set without C3a(70-77) 
and 16 + 2% for the set with 10 -6 M C3a(70-77) before the removal of C3a(70-77) 
by gel filtration. The respective values were 40 + 2% and 20 + 2% for a V100 dilution 
of the pools of LIF after gel filtration. 
In two experiments with T lymphocytes purified by the erythrocyte rosetting 
technique, the LIF activity elicited by 10 gg/ml of PHA induced 20% and 20% 
inhibition of PMN migration from glass capillary tubes, which was suppressed to 1% 
and -10%, respectively, by 10 -8 M C3a(70-77). 
Inhibition of TLymphocyte Migration by C3a(70-77). The addition of 10 -9 M to 10 -6 
M C3a(70-77) to purified human T lymphocytes suppressed the enhanced random 
migration elicited by 1 gg/ml of Con A and 3 × 10 -n M a-thioglycerol in a 
concentration-dependent manner (Table I). The extent of inhibition of T lymphocyte 
migration was significant at or above concentrations of C3a(70-77) of 3 × 10 -9 M for 
the Con A stimulus and of 10 -9 M for a-thioglycerol. The ICs0 for C3a(70-77)was ~3 
× 10 -8 M with Con A and 10 -8 M with a-thioglycerol. 
Lack of Effect of C3a and C3a(70-77) on Lymphocyte Proliferation and Viability. The 
addition of 10 -8 M to 10 -n M C3a(70-77) or 10 -8 M and 10 -7 M C3a to suspensions 
of mononuclear leukocytes without or with PHA, Con A, or SK-SD at the beginning 
TABLE I 
Inhibition of Human T Lymphocyte Migration by C3a (70-77) 
Concentrat ion of C3a(70-77),  molar  
St imulus of  3 × 10 -9 3 X 10 -9 10 -s 3 × 10 -a 10 .7 3 × 10 -7 10 .6 
migrat ion 10 -~° 
Percentage of control-st imulated migrat ion 
mean +. SD;  n = 3 
ConA - -  90±8 76+ 11" 57+ 12" 49± 10" 44+ 11" - -  - -  
a-thioglycerol 96+3 83±2"  72:1 :4"  53±5"  43+5"  39 : t :8"  33±6"  26±4"  
The level of statistical significance of the inhibition of migration by C3a(70-77) relative to the 
corresponding control stimulated migration of T lymphocytes in the absence ofC3a(70-77) (100%) is 
denoted by an asterisk; P < 0.01. 
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of the incubation period failed to suppress significantly the level of uptake of 
[~H]thymidine (Table II). The incubation of mononuelear leukoeytes with 10 -n M 
C3a or 10 -6 M C3a(70-77) for 2-12 h failed to reduce the viability of the leukocytes 
below that of those in medium alone, as assessed by the exclusion of trypan blue dye 
and the level of uptake of [ZH]thymidine in culture. 
Adsorption of LIF-producing Mononuclear Leukocytes on C3a (70-77)-Sepharose. To exam- 
ine the interaction of mononuclear leukocytes with C3a(70-77) more directly, identical 
aliquots of suspensions of mononuclear leukocytes were filtered over a column of 
Sepharose to which had been coupled C3a(70-77) and a control column of Sepharose 
bearing the same molar quantity of glycine. The mean levels of LIF activity generated 
by Con A stimulation of leukocytes in the effluent from control Sepharose columns 
were 42%, 26%, and 32% inhibition of PMN migration, respectively, in three separate 
experiments, whereas the LIF activity generated by Con A stimulation of the 
mononuclear leukocytes in the effluents from C3a(70-77)-Sepharose columns were 
0%, -10%, and -14%. In each of the three experiments, one-half of the leukocytes in 
the effluents from the C3a(70-77)-Sepharose column and from the control column 
were mixed together before stimulation with Con A. The mean levels of LIF generation 
were 36%, 35%, and 39% inhibition of PMN migration, which were not significantly 
different from the levels observed with the same number of mononuclear leukocytes 
from control columns. In addition, 10 -n M C3a(70-77) suppressed the levels of 
generation of LIF activity to 9 + 9% (mean + SEM; n = 3; P < 0.07) for leukocytes 
from control columns and to 4 + 7% (P < 0.01) for the mixtures of leukocytes from 
control and C3a(70-77)-Sepharose columns. The viability of the mononuclear leu- 
kocytes in the effluents ranged from 80-85% for all column procedures, as assessed by 
the exclusion of trypan blue dye, and the recovery ranged from 85-90%. 
The distribution of subclasses of T lymphocytes in the column effluents for two 
consecutive experiments was analyzed in a fluorescence-activated c ll sorter (Ortho 
Spectrum III; Ortho Diagnostic Systems, Westwood, MA) with standardized mouse 
monoclonal antisera to human leukocyte antigens (9). The subpopulations of T 
lymphocytes in the effluents from the control-Sepharose column were 41.9% and 
52.2% OKT4, 67.7% and 82.1% OKT3, and 34.2% and 24.3% OKT8, and in the 
TABLE II 
Effect of C3a and C3a (70-77) on the Proliferative Responses ofHuman Blood Mononuclear Leukocytes 
C3a(70-77)  C3a St imulus  PHA (6)* Con A (8) SK-SD (7) 
% inhibi- % inhibi- 
mean cpm + SEM tmn~ mean epm + SEM tion~ mean cpm + SEM 
- -  - -  - -  400 + 36 580 + 118 2,843 + 897 
10-* M - -  - -  372 ± 41 674 + 129 2,640 + 1,000 
10 -7 M - -  - -  452 ± 62 609 + 104 2,610 :l: 1,048 
10 n M - -  - -  369 -1- 32 580+ 104 2,886:1:968 
- -  10 -8 M - -  712 + 186 930 -1- 251 4,246 ± 1,413 
- -  10 -7 M 618 + 92 1,258 + 327 3,450 ± 1,052 
- -  - -  + 214,195 + 5,093 107,417 + 5,868 41,274 + 15,85l 
10 -a M - -  + 205,446 ± 8,762 5 ± 3 88,289 + 4,916 7 + 2 35,532 + 13,892 
10 7M - -  + 224 ,289+ 7,831 0 101 ,477+4,190 6±2 37 ,798± 14,992 
106M - -  + 212 ,635±11,279 4±4 102,652+5,870 6±3 39 ,734+18,569 
- -  10 -aM + 214,160 + 10,213 5+3 97 ,776+5,431 10+4 33 ,069+14,150 
- -  10 -r  M + 201,225 ± 19,917 10 ± 8 96,681 + 6,526 12 ± 6 32,675 ± 15,328 
% inhibz- 
lion 
24±9 
11±5 
21+8 
32 ± 12 
39± 15 
* The  number  o f  exper iments  per formed is indicated in parentheses. 
In  no  instance was the percent inh ib i t ion  statistically signif icant. 
D. G. PAYAN, D. E. TRENTHAM, AND E. J. GOETZL 763 
respective ffluents from the C3a(70-77)-Sepharose column were 36.6% and 44.1% 
OKT4, 69.5% and 80.6% OKT3, and 33.8% and 22.7% OKT8. The subpopulations 
of T lymphocytes in the effluents from control columns were not different from those 
found in the circulation (9). Thus, the interaction of mononuclear leukocytes with 
solid-phase C3a(70-77) resulted in a relative depletion of the helper/inducer subpop- 
ulation (OKT4), without significant alterations in the suppression/cytotoxic subpop- 
ulation (OKT8) or in the overall representation f lymphocytes (OKT3). 
Discussion 
Diverse activities of lymphocytes are regulated with a high degree of specificity by 
numerous immunological mediators other than antigens and antibodies. Definitive 
characterization f the mechanisms of such lymphocyte responses requires the use of 
structurally defined principles. The direct interaction of purified C3a and C3a(70- 
77) with human mononuclear leukocytes in culture resulted in a concentration- 
dependent inhibition of the generation of LIF evoked by mitogens and by the antigen 
SK-SD (Figs. 1-4). The extent of suppression of LIF generation by C3a(70-77) was 
significant at concentrations of 10 -7 M or higher and exceeded 75% at 10 -6 M, 
irrespective of the stimulus. The same C3a(70-77) concentration-inhibition relation- 
ships were obtained whether LIF was quantified with the capillary tube assay or a 
modified Boyden chamber method. That C3a(70-77) was capable of suppressing 
distinct immunological ctivities of isolated human T lymphocytes was demonstrated 
by two separate approaches, although an action on mononuclear phagocytes has not 
been excluded. First, the generation of LIF by T lymphocytes purified with an 
erythrocyte rosetting technique was inhibited by 10 -s M C3a(70-77) to a similar 
degree as the generation of LIF by mixed mononuclear leukocytes. Second, the 
migration o fT  lymphocytes stimulated by Con A or by a-thioglycerol was suppressed 
significantly by C3a(70-77). The ICs0 of 3 × 10 -s M C3a(70-77) with Con A as the 
stimulus for migration (Table I) was similar to the ICs0 of 10 -s M C3a(70-77) 
observed for the generation of LIF elicited by Con A (Fig. 2). 
The inhibitory effects of C3a on lymphocytes exhibited both functional and 
molecular specificity. At concentrations that suppressed maximally the generation of 
LIF, neither C3a nor C3a(70-77) inhibited significantly the proliferative responses of 
mononuclear leukocytes to mitogens or antigen (Table II). Although C3a(70-77) 
retains only 1-2% of the potency of intact C3a with respect o anaphylatoxin activity 
(6, 9), the generation of LIF by mononuclear leukocytes and T lymphocytes cultured 
with mitogens was suppressed similarly by synthetic C3a(70-77) and purified C3a 
(Figs. 1, 2). In contrast, the potency of C3a was more than 10-fold higher than that 
of C3a(70-77) in terms of the suppression of LIF generation by mononuclear leuko- 
cytes (Fig. 3) and T lymphocytes cultured with the antigen SK-SD. If it is assumed 
that the capacity of C3a to distinguish between antigen- and mitogen-stimulated 
lymphocytes i not a function of other factors contaminating the C3a preparation, 
then it may be concluded that the regulatory effects of C3a reside in more than one 
molecular domain. Only amino acids 70-77 are required for optimum modulation of 
lymphokine production by mitogen-stimulated lymphocytes, whereas one or more 
other domains of C3a might need to be presented to antigen-stimulated lymphocytes 
for maximum inhibitory potency. 
The ability of a C3a(70-77)-Sepharose column to adsorb mononuclear leukocytes 
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critical to the generation of lymphokines was demonstrated by the failure of the 
lymphocytes in the column effluent o generate LIF when challenged with Con A. 
That the loss of LIF-generating activity was not a function of the production of an 
inhibitory factor was proven by the findings of similar levels of LIF in supernatants 
from control ymphocytes and from mixtures composed of an equal number of control 
lymphocytes and of lymphocytes passed through a C3a(70-77)-Sepharose column. 
The data presented do not definitively exclude the possibility that the LIF-generating 
lymphocytes were inactivated, but not adsorbed, on the C3a(70-77)-Sepharose col- 
umn. 
The secondary antibody responses of rat lymph node cells to both thymus-depend- 
ent and thymus-independent a igens in vitro were inhibited by purified human C3 
and fragments of C3 that resembled C3a in molecular weight (7). The suppressive 
effect of C3 and the C3a-like fragments was not attributable to alterations in the 
kinetics of antibody production or to the induction of suppressor populations of 
lymphocytes or macrophages, which suggested the possibility of an action of C3a on 
B lymphocytes. However, the capacity of highly purified human C3a to inhibit the 
production of antibodies by mouse lymphocytes was not dependent on the suppression 
of B lymphocyte proliferation, a finding that implies that C3a may modify the 
function of one or more regulatory subsets o fT  lymphocytes (19). The reduced ability 
of human T lymphocytes to generate lymphokines in the presence of C3a or C3a(70- 
77), irrespective of the nature of the stimulus, and the removal or inactivation by 
solid-phase C3a(70-77) of the lymphocytes required for LIF generation provide direct 
evidence for functional modulation of T lymphocyte-dependent cellular immune 
phenomena by a product of the complement cascade. 
Summary  
Human C3a and the synthetic octapeptide C3a(70-77), which retains the activities 
of an anaphylatoxin, inhibit in a concentration-dependent manner the generation of 
leukocyte i~hibitory factor (LIF) activity by human mononuclear leukocytes and T 
lymphocytes cultured with the mitogens phytohemagglutinin (PHA) or concanavalin 
A (Con A) or the antigen streptokinase-streptodornase (SK-SD). The generation of 
LIF activity was inhibited by 50% by 10 -8 M C3a or C3a(70-77) with PHA or Con 
A as the stimulus, whereas a more than 10-fold higher concentration of C3a(70-77) 
than C3a was required to achieve the same level of suppression with SK-SD as the 
stimulus. Similar concentrations of C3a(70-77) inhibited to the same extent the 
migration of T lymphocytes stimulated by a-thioglycerol r Con A. Neither C3a nor 
C3a(70-77) altered significantly the uptake of [3H]thymidine by human mononuclear 
cells exposed to PHA, Con A, or SK-SD. The capacity of C3a(70-77)-Sepharose, but
not Sepharose alone, to adsorb or inactivate mononuclear leukocytes required for the 
generation of LIF activity established a direct interaction. Analysis of the lymphocytes 
in the effluent from C3a(70-77)-Sepharose columns, using monoclonal antibodies to 
surface antigens, showed a selective depletion of the helper/inducer population of 
lymphocytes. C3a might represent an important mediator of the functionally selective 
regulation of human T lymphocyte activities by the complement system. 
The authors gratefully acknowledge the excellent technical assistance of Roselynn A. 
D. G. PAYAN, D. E. TRENTHAM, AND E. J. GOETZL 
Dynesius-Trentham and Donna Rowland. 
765 
Received for publication 25 March 1982. 
References 
I. Pepys, M. B. 1976. Role of complement in the induction of immunological responses. 
Transplant. Rev. 32:93. 
2. Bianco, C., R. Patrick, and V. Nussenzweig. 1970. A population of lymphocytes bearing a 
membrane receptor for antigen-antibody-complement complexes. I Separation and char- 
acterization.J. Exp. Med. 132:702. 
3. Lay, W. H., and V. Nussenzweig. 1968. Receptors for complement on leukocytes. J. Exp. 
Med. 128:991. 
4. Shore, A., H. M. Dosch, and E. W. Gelfand. 1979. Expression and modulation of C 
receptors during early T-cell ontogeny. Cell, Immunol. 45:157. 
5. Needleman, B. W., J. M. Weiler, and T. L. Feldbush. 1981. The third component of 
complement inhibits human lymphocyte blastogenesis.J. Immunol. 126:1586. 
6. Hugli, T. E., and H. J. Miiller-Eberhard. 1978. Anaphylatoxins: C3a and C5a. Adv. 
Immunol. 26:1. 
7. Hobbs, M. V., T. L. Feldbush, B. W. Needleman, and J. M. Weiler. 1982. Inhibition of 
secondary in vitro antibody responses by the third component of complement. J. Immunol. 
128:1470. 
8. Hugli, T. E., and B. W. Erikson. 1977. Synthetic peptides with the biological activities and 
specificity of human C3a anaphylatoxin. Proc. Natl. Acad. Sci. U. S. A. 74:1826. 
9. Hoffman, R. A., P. C. Kung, P. W. Henson, and G. Goldstein. 1980. Simple and rapid 
measurement of human T-lymphocytes and their subclasses in peripheral blood. Proc. Natl. 
Acad. Sci. U. S. A. 77:4914. 
10. Goetzl, E. J., and K. Y. Hoe. 1979. Chemotactic factor eceptors of human PMN leukocytes. 
I. Effects on migration of labeling plasma membrane determinants with impermeant 
covalent reagents and inhibition of labeling by chemotactic factors. Immunology. 37:407. 
11. Hugli, T. E., E. H. Vallota, and H. J. Miiller-Eberhard. 1975. Purification and partial 
characterization f human and porcine C3a anaphylatoxin.J. Biol. Chem. 250:1472. 
12. Stewart, J. M., and J. D. Young. 1969. Solid-Phase Peptide Synthesis. W. H. Freeman and 
Co., San Francisco. 
13. Dynesius-Trentham, R. A., D. Rowland, E. LaRoehe, and D. Trentham. 1981. Rat 
leukocyte inhibitory factor (LIF): similarities to human LIF and generation by cells from 
rats with collagen-induced arthritis. Cell. Immunol. 63:362. 
14. McCarty, J., and E. J. Goetzl. 1979. Stimulation of human T-lymphocyte chemokinesis by 
arachidonic acid. Cell, Immunol. 43:103. 
15. Boyum, A. 1968. Isolation of leukocytes from human blood: further observations. Scand. J. 
Clin. Lab. Invest, 21(suppl. 97):31. 
16. Wahl, S. M., D. L. Rosenstreich, and J. J. Openheim. 1976. Separation of human 
lymphocytes by E rosette sedimentation. I  In Vitro Methods in Cell-mediated and Tumor 
Immunity. B. R. Bloom and J. R. David, editors. Academic Press, Inc., New York. 231. 
17. Goetzl, E. J., and R. E. Rocklin. 1978. Amplification of the activity of human leukocyte 
inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN 
leukocyte hemotaxis.J. Immunol. 121:891, 
18. Trentham, D. E., A. S. Townes, A. H. Kang, andJ. R. David. 1978. Humoral and cellular 
sensitivity to collagen in Type II collagen-induced arthritis in rats.J. Clin. Invest. 61:89. 
19. Morgan, E. L., W. O. Weigle, and T. E. Hugli. 1981. Are the anaphylatoxins immunoreg- 
ulatory factors? In Proceedings of the IX International Complement Workship, Nov. 22- 
25, Key Biscayne, Florida. 32. 
